Literature DB >> 14500832

3'-modified oligonucleotides by reverse DNA synthesis.

Christopher D Claeboe1, Rong Gao, Sidney M Hecht.   

Abstract

Reverse DNA oligonucleotide synthesis (i.e. from 5'-->3') is a strategy that has yet to be exploited fully. While utilized previously for the construction of alternating 3'-3'- and 5'-5'-linked antisense oligonucleotides, the use of nucleoside 5'-phosphoramidites has not generally been used for the elaboration of (modified) oligonucleotides. Presently, the potential of reverse oligonucleotide synthesis for the facile synthesis of 3'-modified DNAs is illustrated using a phosphoramidite derived from tyrosine. The derived oligonucleotide was shown to have chromatographic and electrophoretic properties identical with the modified oligonucleotide resulting from the proteinase K digestion of the vaccinia topoisomerase I-DNA covalent complex. The results confirm the nature of the structure previously assigned to this product, and establish the facility with which proteinase K is able to complete the digestion of the polypeptide backbone of the DNA oligonucleotide-linked topoisomerase I.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500832      PMCID: PMC206447          DOI: 10.1093/nar/gkg734

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  17 in total

1.  Light-directed, spatially addressable parallel chemical synthesis.

Authors:  S P Fodor; J L Read; M C Pirrung; L Stryer; A T Lu; D Solas
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

2.  New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site.

Authors:  J Q Svejstrup; K Christiansen; I I Gromova; A H Andersen; O Westergaard
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

3.  Gene synthesis machines: DNA chemistry and its uses.

Authors:  M H Caruthers
Journal:  Science       Date:  1985-10-18       Impact factor: 47.728

Review 4.  Eukaryotic DNA topoisomerases I.

Authors:  M Gupta; A Fujimori; Y Pommier
Journal:  Biochim Biophys Acta       Date:  1995-05-17

5.  Light-generated oligonucleotide arrays for rapid DNA sequence analysis.

Authors:  A C Pease; D Solas; E J Sullivan; M T Cronin; C P Holmes; S P Fodor
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

6.  Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system.

Authors:  Y P Tsao; A Russo; G Nyamuswa; R Silber; L F Liu
Journal:  Cancer Res       Date:  1993-12-15       Impact factor: 12.701

7.  Ligation of synthetic activated DNA substrates by site-specific recombinases and topoisomerase I.

Authors:  G Pan; K Luetke; C D Juby; R Brousseau; P Sadowski
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

Review 8.  DNA topoisomerases: essential enzymes and lethal targets.

Authors:  A Y Chen; L F Liu
Journal:  Annu Rev Pharmacol Toxicol       Date:  1994       Impact factor: 13.820

9.  Analysis of products formed during bleomycin-mediated DNA degradation.

Authors:  N Murugesan; C Xu; G M Ehrenfeld; H Sugiyama; R E Kilkuskie; L O Rodriguez; L H Chang; S M Hecht
Journal:  Biochemistry       Date:  1985-10-08       Impact factor: 3.162

10.  Vaccinia DNA topoisomerase I: single-turnover and steady-state kinetic analysis of the DNA strand cleavage and ligation reactions.

Authors:  J T Stivers; S Shuman; A S Mildvan
Journal:  Biochemistry       Date:  1994-01-11       Impact factor: 3.162

View more
  2 in total

1.  Chimeric bifunctional oligonucleotides as a novel tool to invade telomerase assembly.

Authors:  Dulat Azhibek; Maria Zvereva; Timofei Zatsepin; Maria Rubtsova; Olga Dontsova
Journal:  Nucleic Acids Res       Date:  2014-07-31       Impact factor: 16.971

2.  Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia.

Authors:  Kohei Tada; Masayuki Kobayashi; Yoko Takiuchi; Fumie Iwai; Takashi Sakamoto; Kayoko Nagata; Masanobu Shinohara; Katsuhiro Io; Kotaro Shirakawa; Masakatsu Hishizawa; Keisuke Shindo; Norimitsu Kadowaki; Kouji Hirota; Junpei Yamamoto; Shigenori Iwai; Hiroyuki Sasanuma; Shunichi Takeda; Akifumi Takaori-Kondo
Journal:  Sci Adv       Date:  2015-04-24       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.